|
1
|
Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome.
|
Evid Based Complement Alternat Med
|
2007
|
2.22
|
|
2
|
Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial.
|
Psychol Methods
|
2011
|
1.49
|
|
3
|
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
|
J Clin Psychiatry
|
2004
|
1.42
|
|
4
|
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
|
J Psychiatr Res
|
2009
|
1.09
|
|
5
|
A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome.
|
J Clin Psychiatry
|
2015
|
1.07
|
|
6
|
Early changes in prefrontal activity characterize clinical responders to antidepressants.
|
Neuropsychopharmacology
|
2002
|
1.06
|
|
7
|
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.
|
J Psychiatr Res
|
2005
|
1.05
|
|
8
|
Longitudinal progression of subclinical structural brain disease in normal aging.
|
Am J Geriatr Psychiatry
|
2004
|
1.04
|
|
9
|
Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers.
|
Clin Neurophysiol
|
2004
|
1.03
|
|
10
|
Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study.
|
Epilepsy Behav
|
2013
|
1.02
|
|
11
|
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.
|
Arch Neurol
|
2002
|
0.98
|
|
12
|
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
|
Am J Psychiatry
|
2006
|
0.96
|
|
13
|
Characteristics of insured and noninsured outpatients with depression in STAR(*)D.
|
Psychiatr Serv
|
2005
|
0.93
|
|
14
|
Midline and right frontal brain function as a physiologic biomarker of remission in major depression.
|
Psychiatry Res
|
2009
|
0.92
|
|
15
|
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.
|
Clin Neurophysiol
|
2003
|
0.92
|
|
16
|
A genome-wide association study of a sustained pattern of antidepressant response.
|
J Psychiatr Res
|
2013
|
0.90
|
|
17
|
Predictive socioeconomic and clinical profiles of antidepressant response and remission.
|
Depress Anxiety
|
2013
|
0.90
|
|
18
|
Brain electrical source differences between depressed subjects and healthy controls.
|
Brain Topogr
|
2008
|
0.89
|
|
19
|
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
|
Clin Neurophysiol
|
2009
|
0.89
|
|
20
|
Does the clinical course of depression determine improvement in symptoms and quality of life?
|
J Nerv Ment Dis
|
2006
|
0.89
|
|
21
|
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
|
J Clin Psychiatry
|
2005
|
0.87
|
|
22
|
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.
|
Psychiatr Clin North Am
|
2007
|
0.86
|
|
23
|
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.
|
Psychosomatics
|
2005
|
0.85
|
|
24
|
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
|
J Clin Psychopharmacol
|
2010
|
0.85
|
|
25
|
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints.
|
Brain Imaging Behav
|
2013
|
0.85
|
|
26
|
Aging and brain activation with working memory tasks: an fMRI study of connectivity.
|
Int J Geriatr Psychiatry
|
2007
|
0.84
|
|
27
|
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.
|
Psychiatry Res
|
2011
|
0.82
|
|
28
|
Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.
|
Psychopharmacology (Berl)
|
2015
|
0.81
|
|
29
|
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
|
J Neuropsychiatry Clin Neurosci
|
2009
|
0.80
|
|
30
|
Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation).
|
Neurosurg Clin N Am
|
2014
|
0.80
|
|
31
|
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.
|
Neuropsychopharmacology
|
2005
|
0.80
|
|
32
|
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?
|
J Neuropsychiatry Clin Neurosci
|
2013
|
0.79
|
|
33
|
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
|
Int J Geriatr Psychiatry
|
2002
|
0.79
|
|
34
|
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study.
|
Psychooncology
|
2014
|
0.79
|
|
35
|
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.
|
J Clin Psychopharmacol
|
2010
|
0.79
|
|
36
|
Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
|
Maturitas
|
2006
|
0.79
|
|
37
|
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
|
J Clin Psychiatry
|
2013
|
0.79
|
|
38
|
The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
|
J Clin Neurophysiol
|
2011
|
0.78
|
|
39
|
Influence of age, gender, health status, and depression on quantitative EEG.
|
Neuropsychobiology
|
2005
|
0.77
|
|
40
|
Predictors of improved mood over time in clinical trials for major depression.
|
Psychiatry Res
|
2004
|
0.77
|
|
41
|
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
|
Pain Med
|
2009
|
0.76
|
|
42
|
Effects of heart disease on depression treatment: results from the COMED study.
|
Gen Hosp Psychiatry
|
2011
|
0.76
|
|
43
|
Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography.
|
Clin EEG Neurosci
|
2010
|
0.76
|
|
44
|
Does prior antidepressant treatment of major depression impact brain function during current treatment?
|
Eur Neuropsychopharmacol
|
2012
|
0.76
|
|
45
|
Pretreatment neurophysiologic function and ECT response in depression.
|
J ECT
|
2004
|
0.76
|
|
46
|
Insured and non-insured depressed outpatients: how do they compare?
|
Ann Clin Psychiatry
|
2007
|
0.75
|
|
47
|
Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?
|
Med Hypotheses
|
2013
|
0.75
|